Decoy Therapeutics Inc. (DCOY) Form 424B3 — Jul 17, 2026
Decoy Therapeutics filed a prospectus supplement registering up to 3,766,500 shares of common stock for resale by selling stockholders, representing shares issuable upon exercise of warrants issued in a June 2026 private placement. The warrants include 592,217 Pre-Funded Warrants exercisable at $0.0001 per share, 2,961,085 Milestone Warrants exercisable at $5.91 per share subject to milestone events and stockholder approval, and 213,198 Placement Agent Warrants exercisable at $7.3875 per share. The registration covers a substantial number of shares relative to Decoy's 531,968 outstanding shares as of June 9, 2026, representing significant potential dilution if all warrants are exercised.
Key figures
- Gross Proceeds
- $3.5 million (upfront from private placement), ~$19.1 million if all warrants exercised for cash
- Offering Price
- 5.75
- Shares Offered
- 3766500
- Shares Outstanding
- 531968
- Milestone Warrant Exercise Price
- $5.91 per share
- Pre Funded Warrant Exercise Price
- $0.0001 per share
- Placement Agent Warrant Exercise Price
- $7.3875 per share
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.